BACKGROUND AND OBJECTIVES
Low response to antiplatelet therapy may be a risk factor for the development of ischemic complications in patients with non-ST segment elevation acute coronary syndrome… (More)

BACKGROUND
Factor VIII (FVIII) and von Willebrand factor (VWF) are two known quantitative risk factors for venous thromboembolism (VTE).
OBJECTIVES
To identify new loci that could contribute to VTE… (More)

Clopidogrel is a thienopyridine derivative that inhibits ADPinduced platelet aggregation. It is an inactive pro-drug that requires several biotransformation steps before it acquires its antiplatelet… (More)

OBJECTIVE
Adrenomedullin (AM), a potent vasodilatator and antioxidative peptide, was shown recently to be expressed by adipose tissue. The aim of our study was to investigate the precise localization… (More)

BACKGROUND
Metabolic syndrome (MS) has been associated with being born small for gestational age (SGA). In epidemiological studies plasminogen activator inhibitor type-1 (PAI-1) levels have been… (More)

Background/objectives:Lymphocytes have a critical role in visceral adipose tissue (AT) inflammation. The CD28 costimulatory molecule is required for lymphocyte activation and for the development of a… (More)